Bios Clinical Opportunity Fund, LP

Insider Reports History

Entity
Company
Location
1751 River Run, Suite 400, Fort Worth, TX
Signature
Bios Clinical Opportunity Fund, LP By: Bios Equity COF, LP, its general partner By: Bios Capital Management, LP, its general partner By: Bios Advisors, LLC, its general partner By: /s/ Aaron Glenn Louis Fletcher, Manager
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Bios Clinical Opportunity Fund, LP:

Stock Role Class Num Shares Value Price $ Report Date Ownership
COGNITION THERAPEUTICS INC Director, 10%+ Owner Common Stock 500K $525K $1.05 Nov 8, 2023 Direct
ACTUATE THERAPEUTICS, INC. 10%+ Owner Common Stock 84.9K Aug 12, 2024 Directly held by BP Directors, LP
ACTUATE THERAPEUTICS, INC. 10%+ Owner Common Stock 69.4K Aug 12, 2024 Directly held by Circle K Invesco, LP
ACTUATE THERAPEUTICS, INC. 10%+ Owner Common Stock 61K Aug 12, 2024 Direct
ACTUATE THERAPEUTICS, INC. 10%+ Owner Common Stock 8.06K Aug 12, 2024 Directly held by KF Legacy Trust U/A/D December 7, 2016
ACTUATE THERAPEUTICS, INC. 10%+ Owner Common Stock 8.06K Aug 12, 2024 Directly held by MF Legacy Trust U/A/D December 7, 2016

Insider Reports Filed by Bios Clinical Opportunity Fund, LP

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ACTU ACTUATE THERAPEUTICS, INC. Aug 12, 2024 0 $0 3 Aug 12, 2024 10%+ Owner
INAB IN8BIO, INC. Dec 13, 2023 0 $0 3 Dec 15, 2023 10%+ Owner
CGTX COGNITION THERAPEUTICS INC Nov 8, 2023 0 $0 3 Nov 13, 2023 Director, 10%+ Owner